United States Pharmaceuticals and Healthcare Report - Business Monitor International - Industry Reports

United States Pharmaceuticals and Healthcare Report

United States Pharmaceuticals and Healthcare Report - Business Monitor International - Industry Reports
United States Pharmaceuticals and Healthcare Report
Published Aug 20, 2016
113 pages — Published Aug 20, 2016
Price US$ 1,295.00  |  Buy this Report Now

About This Report

  
Abstract:

Metropolitan regions will continue to drive headline economic growth in the US over the coming three to five years. Industry agglomeration, the rising concentration of similar industry-specific companies, will develop supply chains and a region s expertise in certain sectors, attracting further investment and skilled labour. ...Metropolitan regions will continue to drive headline economic growth in the US over the coming three to five years. Industry agglomeration, the rising concentration of similar industry-specific companies, will develop supply chains and a region s expertise in certain sectors, attracting further investment and skilled labour. We are seeing this play out with technology industries in Western metropolitan areas and manufacturing hubs sprouting in the South. ...We are seeing this play out with technology industries in Western metropolitan areas and manufacturing hubs sprouting in the South. In addition, Southern metropolitan areas, including Austin and Miami, will benefit from low operating costs, rising infrastructure spending and expanding transport links that will ease access to both domestic and foreign markets.

...The US has a RRI score of --.- out of --- for Q---. This is unchanged from Q---, and slightly higher than the --.- recorded in Q---. The high RRI score recorded by the US underlines the pharmaceutical market s unassailable status as the most lucrative globally. This is due to unparalleled healthcare access, considerable spending power, a high burden of disease, minimal market access barriers and intense company activity. The key risks to this positive outlook are the increasing influence of pharmacy benefit managers and greater regulation, such as the Branded Prescription Drug Fee. ...This is due to unparalleled healthcare access, considerable spending power, a high burden of disease, minimal market access barriers and intense company activity. The key risks to this positive outlook are the increasing influence of pharmacy benefit managers and greater regulation, such as the Branded Prescription Drug Fee.

...Following the release of ---- financial results for leading drug companies, the expenditure projection for the US pharmaceutical market was revised upwards. We now expect combined sales of prescription drugs and OTC medicines to increase from USD---bn in ---- to USD---bn in ----, representing a compound annual growth rate of -.- . ...

  
Source:
Document ID
1748-3778
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Business Monitor International - Industry Reports—Established in 1984, Business Monitor International is a leading online publisher of specialist business information on global emerging markets. Business Monitor's range of quarterly services covers political risk, finance, macroeconomic performance, outlook and forecast, industry sectors and the business operating environment. Each Industry Report has been researched at source, and features latest-available data covering production, sales, imports and exports; 5-year industry forecasts through end-2012; company rankings and competitive landscapes for multinational and local manufacturers and suppliers; and analysis of latest industry developments, trends and regulatory changes.

About the Author


Cite this Report

  
MLA:
Business Monitor International - Industry Reports. "United States Pharmaceuticals and Healthcare Report" Aug 20, 2016. Alacra Store. Dec 02, 2016. <http://www.alacrastore.com/storecontent/Business-Monitor-International-Industry-Reports/United-States-Pharmaceuticals-and-Healthcare-Report-2026-348>
  
APA:
Business Monitor International - Industry Reports. (2016). United States Pharmaceuticals and Healthcare Report Aug 20, 2016. New York, NY: Alacra Store. Retrieved Dec 02, 2016 from <http://www.alacrastore.com/storecontent/Business-Monitor-International-Industry-Reports/United-States-Pharmaceuticals-and-Healthcare-Report-2026-348>
  
US$ 1,295.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.